Answers are grounded in this paper and cite their sources.
We describe a statistical method for the characterization of genomic aberrations in single nucleotide polymorphism microarray data acquired from cancer genomes. Our approach allows us to model the joint effect of polyploidy, normal DNA contamination and intra-tumour heterogeneity within a single unified Bayesian framework. We demonstrate the efficacy of our method on numerous datasets including laboratory generated mixtures of normal-cancer cell lines and real primary tumours.
No takes yet. Share an insight, caveat, or question.
Yau et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: